Fractyl Health cuts 45% of workforce, focuses on Revita device Oct 22, 2026 07:17AM
Fractyl Health Sharpens Focus on Revita Following Positive Pivotal Results, Advancing Toward Planned FDA De Novo Submission in Post-GLP-1 Weight Maintenance Oct 22, 2026 07:00AM
Fractyl Health Reports First Quarter 2026 Financial Results and Business Updates May 12, 2026 04:05PM
Fractyl Health Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates Mar 24, 2026 04:01PM
Fractyl Health Announces Fourth Quarter and Full Year 2024 Financial Results and Business Updates Mar 3, 2025 04:05PM


Jan 31, 2025 08:01AM Fractyl Health Announces Increased Focus on Groundbreaking Revita® Weight Maintenance and Rejuva® Pancreatic Gene Therapy Programs with Potential to Deliver Key Clinical Milestones Across Multiple S